Tweenvest Stocks

bioAffinity Technologies, Inc. (NasdaqCM: BIAF)

Health Care · Biotechnology · US

$6.16

+1.73% today · -84.2% 1Y

bioAffinity Technologies, Inc. (NasdaqCM: BIAF) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.27M and employs 57 people.

Over the last twelve months the share price has lost 84.2%, trading between 4.56 and 80.70.

Tweenvest scores bioAffinity Technologies, Inc. across four factors: quality 36/100, value 41/100. Its strongest factor is value.

BIAF price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$3.27M
Revenue (TTM)
$5.90M
P/E
—
EPS
-59.70
Dividend yield
—
Beta (5Y)
-1.25
52-week high
$80.70
52-week low
$4.56
Avg volume (3M)
—
Shares outstanding
539.86K
Employees
57
Next earnings
—

About bioAffinity Technologies, Inc.

As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.

ISIN
US09076W4069
Founded
2014
Listed since
Sep 1, 2022
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Mustang Bio, Inc.NasdaqCM: MBIO$3.57M$0.45-4.44%
Nymox Pharmaceutical CorporationOTCPK: NYMX.F$3.36M$0.03-68.00%
Chosa Oncology ABNGM: CHOSA$3.31MSkr——
Restart Life Sciences Corp.CNSX: HEAL$3.30MCA$0.08+7.14%
Propanc Biopharma, Inc.NasdaqCM: PPCB$3.21M$0.50-1.73%
Aptevo Therapeutics Inc.NasdaqCM: APVO$3.17M$1.84+4.55%
HCW Biologics Inc.NasdaqCM: HCWB$3.09M$1.56-7.14%
Revelation Biosciences, Inc.NasdaqCM: REVB$3.04M$0.83+8.45%

Browse every Biotechnology company →

Figures last refreshed Oct 4, 2026.